ACHIEVE Africa logo

Join ACHIEVE Africa at the INTEREST Conference in Dar es Salaam

Join the International Vaccine Institute at the annual International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST) conference in Dar es Salaam for a Special Session focused on advancing Africa’s leadership in vaccine innovation, research and development, and manufacturing sovereignty.

This session will bring together researchers, policymakers, and global partners to explore how Africa can:

  • Accelerate vaccine R&D from discovery to delivery
  • Strengthen manufacturing capacity and supply chains
  • Advance solutions for HIV, TB, mpox, Lassa fever, and emerging threats
  • Build sustainable, sovereign, and resilient health systems

The discussion will also highlight ACHIEVE Africa’s efforts to strengthen end-to-end vaccine ecosystems across the continent through collaboration, innovation, and regional partnerships.

Special Session I: Building Africa’s End-to-End Vaccine R&D and Manufacturing Ecosystem: ACHIEVE Africa’s Vision, Progress, and Roadmap to Sovereignty

12 May 2026 | 4:15–5:00 PM | Dar es Salaam, Tanzania

4:15 PM – Accelerating African Vaccine R&D: The ACHIEVE Africa Platform
Nicaise Ndembi, PhD
International Vaccine Institute/IVI African Regional Office, Rwanda

4:30 PM – Round Table Discussion
Peter Kilmarx, MD
Fogarty International Center, United States

Nyanda Elias Ntinginya, MD, MSc, PhD
National Institute for Medical Research- Mbeya medical Research Center, Tanzania

Betty Nanzigu Mwesigwa, MBBS
Makerere University Water Reed Project, Uganda

Learn more at the INTEREST website: http://interestworkshop.org/sessions/special-session-i/